SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Schedule of disaggregated revenue

The following table provides information about disaggregated revenue by product mix for the three months ended March 31, 2019 and 2018:

	For the Three Months Ended March 31,
	2019		2018
Prescription vitamins	$	1,935,971	$	3,773,392
IMVEXXY®		2,010,680		—
Net revenue	$	3,946,651	$	3,773,392